Serophene is a brand-name medication that contains clomiphene citrate as its active ingredient. It is formulated as a pill and is available in strengths of 25 mg, 50 mg, and 100 mg. Serophene is classified under Women’s Health and is primarily prescribed to stimulate ovulation in women who have difficulty becoming pregnant due to certain ovulatory disorders. In Hong Kong, Serophene is a prescription-only product regulated by the Pharmacy and Poisons Board under the Department of Health.
Clomiphene citrate is a selective estrogen receptor modulator (SERM). It binds to estrogen receptors in the hypothalamus, blocking the normal feedback inhibition that estrogen provides. By reducing perceived estrogen levels, the hypothalamus releases more gonadotropin-releasing hormone (GnRH). This increase in GnRH stimulates the pituitary gland to secrete higher amounts of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The elevated FSH promotes the growth and maturation of ovarian follicles, while the LH surge triggers ovulation.
The onset of action typically occurs within 5 days after the first dose, with ovulation most likely to happen 5-10 days after the final dose of a standard treatment cycle. The drug’s half-life ranges from 5 to 7 days, allowing for once-daily dosing. Clomiphene is well absorbed from the gastrointestinal tract; food does not markedly affect its bioavailability.
Serophene is FDA- and EMA-approved for the treatment of infertility in women who do not ovulate or who have irregular ovulation. It is indicated for:
In Hong Kong, the same indications apply, and the medication is prescribed by obstetricians or fertility specialists after confirming that ovulatory dysfunction is the primary cause of infertility.
Off-label use requires medical supervision and an individualized risk assessment.
Absolute contraindications
Relative contraindications
Special populations
If you have any of the above conditions, discuss alternative options with your healthcare provider.
These effects are generally self-limiting and can be managed by taking the pill with food and maintaining adequate hydration.
If you are taking any prescription medicines, over-the-counter drugs, herbal supplements, or vitamins, inform your prescriber before starting Serophene.
Dosing must be individualized by a reproductive specialist who will monitor follicular development with ultrasound.
Regular follow-up appointments allow the clinician to adjust dosing, evaluate treatment success, and detect any complications early.
This article provides educational information about Serophene and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
No. Serophene’s mechanism targets hormonal pathways involved in ovulation and does not influence metabolic rate or appetite. Using it for weight loss is unsupported by clinical evidence and may expose the user to unnecessary risks.
A serum pregnancy test is usually performed about two weeks after the estimated date of ovulation. If ovulation occurred during the treatment cycle, a positive result can be confirmed at that time.
If a cyst is detected during ultrasound monitoring, the prescribing clinician may adjust the dose, pause treatment, or recommend alternative therapies. Prompt medical evaluation is essential.
Yes, provided you carry the medication in its original labeled container, have a copy of the prescription, and are aware of import regulations for prescription drugs in the destination country. Keep the pills in your carry-on luggage to avoid temperature extremes.
Serophene is a specific brand; however, generic clomiphene tablets may contain varying fillers, binders, or dyes. Patients with known allergies to excipients should discuss alternatives with their pharmacist.
Clomiphene is sometimes used as part of ovarian stimulation protocols before IVF, but the decision depends on individual treatment plans. Your fertility specialist will determine whether Serophene is appropriate in conjunction with IVF.
Both drugs stimulate ovulation, but clomiphene (Serophene) acts as a estrogen receptor modulator, whereas letrozole is an aromatase inhibitor that reduces estrogen synthesis. The choice depends on patient response, side-effect profile, and physician preference.
Symptoms include rapid weight gain, severe abdominal or pelvic pain, bloating, shortness of breath, and decreased urine output. If any of these occur, seek immediate medical attention.
The active ingredient, clomiphene citrate, is synthetic and not derived from animal sources. However, inactive ingredients (e.g., lactose) may be present in some formulations. Verify with the manufacturer or pharmacist if vegan compliance is required.
